This is a Biotech company founded in 2006 by Dr. Jordi Mestres as a spin-off from the Hospital del Mar Medical Research Institute (IMIM)
Read moreFlow Chemistry is a key enabling technology that has proven to be particularly advantageous for certain syntheses. Its inherent characteristics offer a wide range of benefits: reactions cannot only be...
Read moreSOM Biotech will attend the “Chiba Global Healthcare Business Forum 2021” on February 3rd – 4th, which will take place digitally due to the pandemic situation.
Read moreSOM Biotech announces its participation at the Drug Discovery Innovation Programme event 2020, being held virtually on November 17th. The conference will be chaired by Kevin McAllister, PhD, MBA Chief...
Read moreThe virtual gathering, one of the most relevant venues for the biotech industry worldwide, allowed SOM biotech to hold more than 70 meetings with key potential business partners and identify opportuni...
Read moreThe Chemical Checker provides processed, harmonized and ready-to-use bioactivity information on more than 1M small molecules. The tool, developed by the Structural Bioinformatics and Network Biology l...
Read moreThe consortium is bringing together a unique group of microbiologists, cancer biologists, chemists, material scientists, mechanical engineers, ocular pharmacologists, geneticists and toxicologists fro...
Read moreEl Dr. Ramon Reñé, responsable de la Unidad Funcional de Demencias del Hospital Universitario de Bellvitge (UFD-HUB), destaca que “la espectacular mejora en el diagnóstico precoz a la que hemos a...
Read moreThe symposium is organized jointly by the Medicinal Chemistry Section of the Swedish Pharmaceutical Society and ENABLE, one of the projects in the Innovative Medicines Initiative ND4BB in which MEDINA...
Read moreNostrum BioDiscovery has come about from the combined efforts of IRB Barcelona and the BSC-CNS—two research centres of excellence in Barcelona—with the participation of the University of Barcelona...
Read moreA drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin, finds new research in mice ...
Read moreThe designed compounds have particularly high therapeutic effects on tumour cells of breast and colon and can be the basis for the development of oncological drugs of low toxicity and high selectivity...
Read more